Last $3.23 USD
Change Today +0.01 / 0.31%
Volume 42.3K
OCLS On Other Exchanges
OCLS is not on other exchanges.
As of 3:47 PM 04/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert E. Miller

Chief Financial Officer, Chief Operating Officer, Principal Accounting Officer and Corporate Secretary, Oculus Innovative Sciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Robert E. Miller has been the Chief Financial Officer of Oculus Innovative Sciences Inc. since June 2004, serves as its Principal Accounting Officer and Chief Operating Officer. Mr. Miller is a Financial Consultant of SCANIS, Incorporated. He has over 12 years of experience as Chief Financial Officer for companies up to $650 million. Mr. Miller's early career was with Merrill Lynch and Blyth Eastman Dillion, Inc., where he served as Vice President of Investment Banking. ...

Read Full Background

Corporate Headquarters*

1129 North Mcdowell Boulevard
Petaluma, California 94954

United States

Phone: 707-283-0550
Fax: 707-283-0551

Board Members Memberships*

Financial Consultant and Board Member


The Board of Trustees of The Leland Stanford Junior University
Columbia Business School
Columbia University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$250,000

Stock Options*

All Other Compensation$12,331
Exercisable Options90,574
Unexercisable Options31,151
Total Number of Options121,725

Total Compensation*

Total Annual Cash Compensation$262,331
Total Short Term Compensation$250,000
Other Long Term Compensation$12,331
Total Calculated Compensation$363,821
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCLS:US $3.23 USD +0.01


Peter J. Arduini Chief Executive Officer, President, Director and Member of Special Award Committee
Integra LifeSciences Holdings Corporation
Olivier Bohuon Chief Executive Officer, Director, Chairman of Disclosures Committee, Chairman of Executive Risk Committee, Member of Nomination & Governance Committee and Member of Nomination & Governance Committee
Smith & Nephew plc
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OCULUS INNOVATIVE SCIENCES I, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at